Chuck Royce acquired 966 Thousand Haemonetics shares worth $90.1 Million. That's 0.81% of their equity portfolio (9th largest holding). The investor owns 1.90% of the outstanding Haemonetics stock. The first Haemonetics trade was made in Q2 2013. Since then Chuck Royce bought shares sixteen more times and sold shares on eight occasions. The stake costed the investor $80.3 Million, netting the investor a gain of 12% so far.